Laurus Labs: End-to-End Research in a Structured Sprint
Delivered a full equity research report on Laurus Labs by breaking the work into a disciplined day-by-day research sprint.
Rohit Kumar Singh
Data Analyst at S&P Global
Overview
Rohit's most recently published report was on Laurus Labs, a pharmaceutical company. He used it as an example of how he structures independent research from brief to delivery within a defined timeframe.
The Story
Rohit's most recently published report was on Laurus Labs, a pharmaceutical company. He used it as an example of how he structures independent research from brief to delivery within a defined timeframe.
He allocated roughly seven days to the project and divided the work by phase. The first two days were dedicated to understanding the business model and mapping the competitive landscape, which required segmenting the pharmaceutical sector carefully given its breadth across generics, biotech, and specialty healthcare.
Day three covered industry analysis: the scope of the sector, growth drivers, and structural tailwinds. He then spent one day on valuation modeling and a final day on report construction and formatting.
When he hit friction, he returned to his accumulated research notes and prior frameworks rather than starting from scratch. He described this as a consistent habit: keeping a well-organized record of past learnings that he can draw on when a new situation resembles a prior one.
The report was published as part of his ongoing independent equity research portfolio.